Cargando…
Optimizing the Development Strategy of Combination Therapy in Respiratory Medicine: From Isolated Airways to Patients
The current recommendations for the treatment of chronic obstructive pulmonary disease (COPD) are pushing towards triple combination therapy based on the combination of an inhaled corticosteroid (ICS) associated with two bronchodilator agents. However, dual bronchodilation remains the cornerstone fo...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6860506/ https://www.ncbi.nlm.nih.gov/pubmed/31654332 http://dx.doi.org/10.1007/s12325-019-01119-w |